Cargando…
Anti-Colorectal Cancer Effects of a Novel Camptothecin Derivative PCC0208037 In Vitro and In Vivo
Colorectal cancer is one of the most common malignancies, and the topoisomerase inhibitor irinotecan (CPT-11)-based chemotherapeutic regimen is currently the first-line treatment with impressive therapeutic efficacy. However, irinotecan has several clinically significant side effects, including diar...
Autores principales: | Li, Min, Wang, Linxu, Wei, Yingjie, Wang, Wenyan, Liu, Zongliang, Zuo, Aixia, Liu, Wanhui, Tian, Jingwei, Wang, Hongbo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9862597/ https://www.ncbi.nlm.nih.gov/pubmed/36678550 http://dx.doi.org/10.3390/ph16010053 |
Ejemplares similares
-
PCC0208017, a novel small-molecule inhibitor of MARK3/MARK4, suppresses glioma progression in vitro and in vivo
por: Li, Fangfang, et al.
Publicado: (2020) -
In Vitro and In Vivo Characterization of PCC0104005, a Novel Modulator of Serotonin-Dopamine Activity, as an Atypical Antipsychotic Drug
por: Xu, Yanan, et al.
Publicado: (2018) -
PCC0208018 exerts antitumor effects by activating effector T cells
por: Ge, Minmin, et al.
Publicado: (2019) -
Carrier-free nanoparticles of camptothecin prodrug for chemo-photothermal therapy: the making, in vitro and in vivo testing
por: Ao, Mingtao, et al.
Publicado: (2021) -
PCC0208009 enhances the anti-tumor effects of temozolomide through
direct inhibition and transcriptional regulation of indoleamine 2,3-dioxygenase
in glioma models
por: Sun, Shanyue, et al.
Publicado: (2018)